Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface
Patent
·
OSTI ID:1176025
The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.
- Research Organization:
- University of Georgia, Athens, GA (Unites States); Abeome Corporation, Athens, GA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- FG07-96ER20257
- Assignee:
- University of Georgia Research Foundation, Inc. (Athens, GA) ; Abeome Corporation (Athens, GA)
- Patent Number(s):
- 7,148,040
- Application Number:
- 10/079,130
- OSTI ID:
- 1176025
- Resource Relation:
- Patent File Date: 2002 Feb 20
- Country of Publication:
- United States
- Language:
- English
Similar Records
Hybridoma cells secreting a monoclonal antibody specific for 5-bromo and 5-iodoeoxyuridine and reagent for measuring cellular proliferation
Production and characterization of monoclonal antibody against a triple negative breast cancer cell line
Characterization of rat basophilic leukemia cell surface proteins using monoclonal antibodies
Patent
·
Tue Jul 16 00:00:00 EDT 1985
·
OSTI ID:1176025
Production and characterization of monoclonal antibody against a triple negative breast cancer cell line
Journal Article
·
Mon Oct 15 00:00:00 EDT 2018
· Biochemical and Biophysical Research Communications
·
OSTI ID:1176025
+2 more
Characterization of rat basophilic leukemia cell surface proteins using monoclonal antibodies
Thesis/Dissertation
·
Fri Jan 01 00:00:00 EST 1988
·
OSTI ID:1176025